Manufacturing Systems and Controls STREAM

  1. Data Quality, Collection, Storage, And Security 9/17/2024

    AI/ML systems perform best when trained on quality data. Here, our panelists discuss what to consider when it comes to AI and collecting, protecting, and storing data in biomanufacturing.

  2. Boost Scalability And Efficiency With Automated Filtration 1/7/2026

    Boost scalability in bioprocessing with automated filtration solutions designed for commercial-scale operations. Achieve reliable performance, low working volumes, and large filtration areas.

  3. Cell Insights By Umetrics® Studio 12/2/2024

    Cell Insights by Umetrics® Studio simplifies advanced data analytics for bioprocessing, offering hybrid modeling, virtual bioreactor simulations, and cell insights to streamline development, and support data-driven decisions.

  4. Adoption And Implementation 9/17/2024

    Here, our panelists share their thoughts on what factors to consider when adopting or implementing new AI/ML technology into your biomanufacturing process.

  5. Commercial Readiness with Orca Bio's Dan Kirby 9/14/2023

    Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.

  6. A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems 11/10/2025

    In this webinar, we will share a variety of strategies for implementing and validating microbial identification systems in the cGMP environment, possible difficulties along the way, and a comprehensive solution that addresses these challenges.

  7. Training AI Models 9/17/2024

    In this segment from the Bioprocess Online Live, “A Realistic Look At AI/ML In Biomanufacturing,” panelists talk about what makes a good AI model and highlight considerations for training these models.

  8. CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt 10/25/2023

    What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract development and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?

  9. The Future Of QC: Robotics And Automation 5/13/2025

    See how pharma 4.0 is revolutionizing the pharmaceutical industry with automation and digitalization to transform microbiological quality control labs into efficient, real-time-monitored environments that enhance productivity.

  10. A Closed And Automated Solution For Cell Therapy Manufacturing 3/1/2024

    Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.